Tag: Cancer: Breast
Interval Breast Cancers Tied to Worse Outcomes
Risk for breast cancer death more than threefold higher for interval versus screen-detected cancer
CDC: One-Year Survival 96.1 Percent for Male Breast Cancer
Relative survival varies by stage at diagnosis, from 98.7 to 25.9 percent for localized and distant stage, respectively
Addition of Radiotherapy for DCIS Cuts Risk for Subsequent Cancer
Risk higher in first five years of follow-up for those treated with breast-conserving surgery alone
CAC Helps ID CVD Risk in Women Receiving RT for Breast Cancer
Higher CAC score calculated from radiotherapy-planning CT scan linked to increased risk for CVD
Abemaciclib Beneficial for HR+, HER2− Early Breast Cancer
Significant improvements seen in rates of invasive disease-free survival, distant recurrence-free survival
Ductal Carcinoma In Situ Tied to Threefold Higher Risk for Death
Risk for dying from breast cancer remains elevated 15 years after initial diagnosis
Black Women Receive Less Timely Breast Cancer Treatment
Trend persists regardless of socioeconomic status
Spironolactone Not Tied to Breast Cancer Recurrence
Drug can be used for alopecia treatment in breast cancer survivors
Long-Term Outcomes Stable After Breast Reconstruction
Stability seen in both long-term surgeon- and patient-reported outcomes data
Survival Worse for Breast Cancers Secondary to Childhood Cancer
Breast cancer-specific survival decreased for women previously treated with radiation for a primary cancer
